8-KOther Events

QUEST DIAGNOSTICS INC 8-K Report (Jan 27, 2004)

Filed January 27, 2004For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on January 27, 2004, primarily to announce its financial results for the fourth quarter and full year ended December 31, 2003. The filing serves as a public disclosure mechanism under Regulation FD, ensuring that all investors receive the information simultaneously. The key takeaway for investors is the company's performance during this period, as detailed in the accompanying press release. While the 8-K itself does not contain the detailed financial figures, it directs investors to Exhibit 99.1, a press release, which would provide the actual revenue, earnings, and other relevant financial metrics. Investors should review this press release to understand the company's profitability, operational efficiency, and any forward-looking statements or guidance provided by management for the upcoming periods. This filing is crucial for assessing the company's financial health and strategic direction.

Key Highlights

  • 1Quest Diagnostics filed an 8-K on January 27, 2004, to report its financial results.
  • 2The report covers the fourth quarter and the full year ended December 31, 2003.
  • 3The primary information is contained within an attached press release (Exhibit 99.1).
  • 4The filing adheres to Regulation FD, ensuring timely and broad public disclosure.
  • 5Investors are directed to the press release for detailed financial performance metrics.
  • 6The Chief Financial Officer, Robert A. Hagemann, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce Quest Diagnostics' financial results for the fourth quarter and the full year ended December 31, 2003, in compliance with Regulation FD.

The detailed financial results are not included directly in the 8-K form itself. They are provided in Exhibit 99.1, which is a press release attached to this filing.

Regulation FD (Fair Disclosure) is an SEC rule that requires public companies to disclose material non-public information to the public in a manner that prevents selective disclosure.

Investors should look for key financial metrics such as revenue, net income, earnings per share (EPS), operating margins, and any management commentary on performance drivers and future outlook or guidance provided by Quest Diagnostics.